News J&J rumoured to be sizing up $12bn Genmab acquisition Speculation mounts that J&J will bid for R&D partner
News Merck KGaA/Pfizer's Bavencio fails in stomach cancer trial Merck KGaA and Pfizer’s cancer immunotherapy Bavencio has disappointed in a hard to treat late-stage gastric cancer trial, failing to extend survival compared to chemotherapy.
News Eisai: UK gives pharma a poor deal, may invest elsewhere Japanese pharma getting frustrated with NICE
News NICE rejects Eisai's Halaven in new breast cancer use NICE rejects drug after finding gap in clinical data
News Researchers start trial on AZ WEE1 drug in head and neck can... Phase 1 trial investigates use before and after surgery
News NHS braces for tough winter, saying budget falls short Cancer and A&E waiting times may not recover
News Obesity needs a new clinical definition, study finds The current definition of obesity based on BMI isn't nuanced enough to gauge health and the need for weight-loss therapies, according to a new study.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
